6560-72-1

Basic information

• Product Name: 1-benzyl-3-methylpiperidin-3-ol
• CAS NO: 6560-72-1
• Molecular Formula: C₁₃H₁₉NO
• Molecular Weight: 205.2961
• Mol File: 6560-72-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 300.2°C at 760 mmHg
• Flash Point: 72.5°C
• Density: 1.073g/cm³
• Vapor Pressure: 0.000507mmHg at 25°C
• Refractive Index: 1.561
• CAS DataBase Reference: 1-benzyl-3-methylpiperidin-3-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzyl-3-methylpiperidin-3-ol(6560-72-1)
• EPA Substance Registry System: 1-benzyl-3-methylpiperidin-3-ol(6560-72-1)

Safety Data

• Hazardous Substances Data: 6560-72-1(Hazardous Substances Data)

Usage

Chemical class

Piperidines
A class of chemical compounds containing a piperidine ring.

Structure

Tertiary amine
An amine with three alkyl or aryl groups attached to the nitrogen atom.

Functional groups

Benzyl group, methyl group, and hydroxyl group

Benzyl group

A phenyl ring attached to a methyl group.

Methyl group

A carbon atom with three hydrogen atoms.

Hydroxyl group

An oxygen atom bonded to a hydrogen atom (-OH).

Central nervous system depressant

Potential pharmaceutical property
Ability to calm or sedate the central nervous system.

Analgesic

Potential pharmaceutical property
Ability to relieve pain.

Applications

Pain management and anesthesia medications
Possible use in developing drugs for managing pain and inducing anesthesia.

Precursor in synthesis

Potential use in organic chemistry
A starting compound used to create other organic compounds.

Further research needed

Chemical and pharmacological properties and potential uses
More studies are required to fully understand the compound's properties and applications in various fields.

Upstream product

• 40114-49-6 1-benzyl-3-piperidone 
• 917-54-4 methyllithium 
• 50606-58-1 N-benzyl-3-piperidinone hydrochloride 

Downstream Products

• 473730-88-0 3-methylpiperidin-3-ol 
• 40240-24-2 1-benzyl-5-methyl-1,2,3,6-tetrahydropyridine 

Relevant articles and documents

THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of Formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of Formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.